← All organizations
Highest phase reached
Phase 4
Timeline
2000s
- Jun 1, 2006
Sarfez Pharmaceuticals, Inc.— Founded
2020s
- Jun 14, 2021
torsemide— Marketing Organization
Drugs by trial phase (4 distinct, 11 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (2 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Marketed drugs (1)
Recent trials (17)
- NCT07223502Lead sponsorPhase 3Dec 1, 2025
- NCT07223502OfficialPhase 3Dec 1, 2025
- NCT07015671OfficialPhase 3Jul 1, 2025
- NCT07015671Lead sponsorPhase 3Jul 1, 2025
- NCT07046975OfficialPhase 3Jun 15, 2025
- NCT07043634OfficialPhase 3Jun 15, 2025
- NCT07043634Lead sponsorPhase 3Jun 15, 2025
- NCT07046975Lead sponsorPhase 3Jun 15, 2025
- NCT06995144OfficialPhase 4May 28, 2025
- NCT06995144Lead sponsorPhase 4May 28, 2025
- NCT06708611Lead sponsorPhase 4Nov 6, 2024
- NCT06206512Lead sponsorPhase 2Jun 30, 2024
- NCT06176794CollaboratorPhase 2Jan 31, 2024
- NCT03509545Lead sponsorPhase 1Jul 17, 2018
- NCT03215875Overall official - principal investigatorPhase 1Oct 17, 2017
Details
- Founded
- Vienna, VA, US Jun 1, 2006
- Last known activity
- Dec 1, 2025